Literature DB >> 15463959

Gene delivery systems--gene therapy vectors for cystic fibrosis.

Daniel Klink1, Dirk Schindelhauer, Andreas Laner, Torry Tucker, Zsuzsanna Bebok, Erik M Schwiebert, A Christopher Boyd, Bob J Scholte.   

Abstract

Gene delivery systems (GDS) play a central role in the development of gene therapy strategies for Cystic Fibrosis (CF). Further, these systems are important tools in studies with cultured cells and in animal models. In this review, we describe the properties of several viral and synthetic gene delivery systems, and evaluate their possible application in gene therapy of CF. While many gene delivery systems give satisfactory results in cultured or animal studies, none of these systems has been shown to fulfil all the requirements of safety and efficacy for use in CF patients. The intact airway epithelium, the most important target in CF gene therapy, proves to be well protected against invading vector systems.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15463959     DOI: 10.1016/j.jcf.2004.05.042

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.482


  5 in total

1.  α-Fetoprotein gene delivery to the nasal epithelium of nonhuman primates by human parainfluenza viral vectors.

Authors:  Liqun Zhang; Maria P Limberis; Catherine Thompson; Marcelo B Antunes; Cindy Luongo; James M Wilson; Peter L Collins; Raymond J Pickles
Journal:  Hum Gene Ther       Date:  2010-11-03       Impact factor: 5.695

2.  REV1 is implicated in the development of carcinogen-induced lung cancer.

Authors:  Chad A Dumstorf; Suparna Mukhopadhyay; Elangovan Krishnan; Bodduluri Haribabu; W Glenn McGregor
Journal:  Mol Cancer Res       Date:  2009-01-27       Impact factor: 5.852

3.  Development of lentiviral vectors with regulated respiratory epithelial expression in vivo.

Authors:  Benjamin Hendrickson; Dinithi Senadheera; Suparna Mishra; Kim Chi T Bui; Xingchao Wang; Belinda Chan; Denise Petersen; Karen Pepper; Carolyn Lutzko
Journal:  Am J Respir Cell Mol Biol       Date:  2007-06-15       Impact factor: 6.914

4.  Gene therapy for C-26 colon cancer using heparin-polyethyleneimine nanoparticle-mediated survivin T34A.

Authors:  Ling Zhang; Xiang Gao; Ke Men; Bilan Wang; Shuang Zhang; Jinfeng Qiu; Meijuan Huang; Maling Gou; Ning Huang; Zhiyong Qian; Xia Zhao; Yuquan Wei
Journal:  Int J Nanomedicine       Date:  2011-10-19

5.  Efficient gene delivery to human umbilical cord mesenchymal stem cells by cationized Porphyra yezoensis polysaccharide nanoparticles.

Authors:  Qingtong Yu; Jin Cao; Baoding Chen; Wenwen Deng; Xia Cao; Jingjing Chen; Yan Wang; Shicheng Wang; Jiangnan Yu; Ximing Xu; Xiangdong Gao
Journal:  Int J Nanomedicine       Date:  2015-11-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.